MEDIMASS
MediMass develops and commercializes technologies to accelerate the in vivo analysis of biological tissues. The company offers Intelligent Surgical Device, which distinguishes between malignant tumor cells and the surrounding healthy tissue during cancer surgery, and enables the operation of skin, breast, and testicle areas. Its product provides information related to early or advanced stage cancer.
MEDIMASS
Industry:
Biotechnology Medical Device
Founded:
2008-03-01
Address:
Budapest, Budapest, Hungary
Country:
Hungary
Total Employee:
11+
Status:
Active
Total Funding:
0
Similar Organizations
Amaxa Biosystems
Amaxa Biosystems develops and commercializes gene transfer technologies and products.
BigDNA
BigDNA develops and commercializes vaccination technologies.
Deliverics
Deliverics develops and commercializes transfection reagent kits.
MR confon
MR confon develops and commercialize high end medicine products.
Recherche Techniques Dentaires
RTD developed and commercialized the fiber- reinforced composite posts.
Investors List
Euroventures
Euroventures investment in Venture Round - MediMass
FastVentures
FastVentures investment in Seed Round - MediMass
More informations about "MediMass"
MediMass - Crunchbase Company Profile & Funding
MediMass develops and commercializes technologies to accelerate the in vivo analysis of biological tissues. The company offers Intelligent Surgical Device, which distinguishes between malignant tumor cells and the surrounding …See details»
MediMass Company Profile 2024: Valuation, Investors ... - PitchBook
Developer and provider of technologies to accelerate the in vivo analysis of biological tissues. The company offers intelligent surgical device, that distinguishes between malignant tumor cells …See details»
MediMass - Products, Competitors, Financials, Employees, …
MediMass develops and commercializes technologies to accelerate the in vivo analysis of biological tissues. Use the CB Insights Platform to explore MediMass's full profile.See details»
MediMass - LinkedIn
MediMass | 220 followers on LinkedIn. Chemical Imaging for Life MediMass Ltd. develops and commercializes technologies to dramatically accelerate the in vivo analysis of biological tissues.See details»
MediMass Overview | SignalHire Company Profile
MediMass develops and commercializes technologies to accelerate the in vivo analysis of biological tissues. The company offers Intelligent Surgical Device, which distinguishes …See details»
MediMass Kft. - life-sciences-europe.com
Jan 1, 2008 · MediMass Kft. https://www.medimass.com The Company was launched in 2008 as a Semmelweis University related start-up to conduct research and development work based …See details»
MediMass - Ownership and Business Overview - Mergr
MediMass is a privately held start-up that develops and commercializes technologies to dramatically accelerate the in vivo analysis of biological tissues. MediMass was founded in …See details»
MediMass (Rapid Evaporative Ionisation Mass Spectrometry)
Information on acquisition, funding, investors, and executives for MediMass (Rapid Evaporative Ionisation Mass Spectrometry). Use the PitchBook Platform to explore the full profile. Request …See details»
Waters Corporation acquires MediMass - 2014-07-22 - Crunchbase
Jul 22, 2014 · MediMass MediMass develops and commercializes technologies. Acquiring Organization: Waters Corporation Waters Corporation creates business advantages for …See details»
MediMass - Funding, Financials, Valuation & Investors - Crunchbase
MediMass has raised 2 rounds. Their latest funding was raised on Nov 23, 2011 from a Venture - Series Unknown round. MediMass is funded by 2 investors. Euroventures and FastVentures …See details»
MediMass Ltd. - Drug pipelines, Patents, Clinical trials - Synapse
Explore MediMass Ltd. with its drug pipeline, therapeutic area, technology platform, 5 literature.See details»
Hungarian startup seeks med tech partner for intelligent cancer knife
Jul 18, 2013 · The iKnife device, developed by Budapest-based MediMass, has wowed researchers in early testing, and now the Budapest company's CEO says he's close to …See details»
Waters Corporation purchases mass spectrometry assets from …
Waters Corporation has acquired Rapid Evaporative Ionisation Mass Spectrometry (REIMS) technology from Hungarian company MediMass for an undisclosed sum. The REIMS …See details»
Waters Strengthens Mass Spec Portfolio with Acquisition of …
Jul 22, 2014 · Waters has acquired the Rapid Evaporative Ionization Mass Spectrometry (REIMS) technology from MediMass. REIMS is an ionization technique that can be used as a source for …See details»
Waters broadens mass spec offering with REIMS acquisition
Jul 29, 2014 · Analytic science company Waters has acquired all of the assets of MediMass, which includes its Rapid Evaporative Ionization Mass Spectrometry (REIMS) technology, as …See details»
New partnership forged to accelerate the development of iKnife ...
Aug 8, 2014 · Waters Corporation (MA, USA) has announced the acquisition of MediMass Ltd’s (Budapest, Hungary) Rapid Evaporative Ionisation MS (REIMS) – the enabling technology for …See details»
iKnife “Sniffing Scalpel” Technology Could Revolutionize Breast …
Aug 26, 2014 · Last month, Waters Corporation of Milford, Massachusetts, a leading analytical instrument manufacturer, announced that it has secured a deal to acquire the technology …See details»
Rapid evaporation ion mass spectrometry technology
Aug 15, 2014 · Waters Corporation has acquired Rapid Evaporative Ionisation Mass Spectrometry (REIMS) technology from MediMass Ltd.See details»
Waters Acquires REIMS Technology | Technology Networks
Jul 22, 2014 · Waters announced the acquisition of Rapid Evaporative Ionization Mass Spectrometry (REIMS) technology from MediMass Ltd. The REIMS technology represents …See details»
Waters acquires REIMS technology | Scientific Computing World
Waters Corporation has announced the acquisition of Rapid Evaporative Ionization Mass Spectrometry (REIMS) technology from MediMass Ltd. The REIMS technology represents …See details»